DUNBAR PHARMA
GMP Certified Cannabinoid APIs
EU cGMP-certified manufacturing of pharmaceutical-grade cannabinoid APIs, prioritising patient safety, active ingredient purity and therapeutic consistency.
About Us
Dunbar Pharma is an Irish GMP manufacturer specialising in pharmaceutical-grade cannabinoid APIs. With cutting-edge R&D and strict quality control, we advance cannabinoid science for global markets.
GMP-Certified Manufacturing
Pharmaceutical-Grade Cannabinoid APIs
Advanced R&D & Quality Control
Global Market Distribution
Dunbar Pharma
Capabilities
API
Manufacturing
EU cGMP-certified facility in Ireland producing high-quality cannabinoid APIs with in-house testing, stability, and flexible supply agreements.
GMP-Certified Facility
In-House Testing
Flexible Supply Options
Research & Development
Innovative in-house R&D advancing cannabinoid API development, formulation, and stability with pharmaceutical-grade process expertise.
In-House R&D
Stability Studies
Cannabinoid Chemistry
Quality Control
& Compliance
Rigorous in-house quality control ensures 96–99% Dronabinol purity, full traceability, and batch-specific Certificates of Analysis.
96–99% Purity
Batch COAs
Full Traceability
Product Highlight
About Dronabinol
Dunbar Pharma’s plant-derived, EU GMP-certified Dronabinol API offers a superior, natural alternative to synthetic versions. Used for nausea, pain, and appetite loss, it enhances patient outcomes with improved bioavailability and consistency.
1972-08-3
CAS Number
C₂₁H₃₀O₂
Molecular Formula
Quality Assurance
& Compliance
Our dedicated team ensures pharmaceutical-grade purity and global regulatory compliance through rigorous testing, in-house stability programs, and GMP-certified systems. Every batch meets the highest standards for safety, efficacy, and transparency, with continuous process improvement at the core of our operations.